Anhui Anke BioTech Group (300009) — Long-term Investment Intensity
Anhui Anke BioTech Group (300009) has a Long-term Investment Intensity of 6.0% as of September 2019. Long-term investments of CN¥194.12 Million represent 6.0% of total assets of CN¥3.25 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Anhui Anke BioTech Group (300009) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Anhui Anke BioTech Group Long-term Investment Intensity (2016–2018)
This chart shows how Anhui Anke BioTech Group's Long-term Investment Intensity has evolved across 3 annual periods from 2016 to 2018. As of September 2019, the intensity stands at 6.0%, reflecting long-term investments of CN¥194.12 Million against total assets of CN¥3.25 Billion CNY. Explore 300009 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Anhui Anke BioTech Group (2016–2018)
The table below presents the year-by-year Long-term Investment Intensity for Anhui Anke BioTech Group from 2016 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 300009 company net worth.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 7.9% | CN¥200.15 Million | CN¥2.53 Billion | ▲ +1.4 pp |
| 2017 | 6.5% | CN¥146.68 Million | CN¥2.25 Billion | ▲ +4.6 pp |
| 2016 | 1.9% | CN¥36.74 Million | CN¥1.97 Billion | — |